Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole
- PMID: 31006179
- PMCID: PMC6688082
- DOI: 10.1002/iid3.250
Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole
Abstract
Introduction: Trichosporon asahii is an emerging cause of systemic fungal infection in an immunocompromised host. Several life threatening disseminated T. asahii infection in single solid organ (liver or kidney) transplant recipients, in neutropenic and hematological malignancy patients have been reported.
Case presentation (methods and results): A 49-year old gentleman who underwent simultaneous living-donor liver transplantation (donor sister) and kidney transplant (donor wife) developed fever and subsegmental patchy consolidation with right sided pleural effusion on fourth postoperative day. Central line blood stream infection was suspected. Blood culture grew creamy white colonies of T. asahii on blood agar with characteristic dirty-green colonies on CHROMagar. Laboratory analysis of pleural fluid also revealed budding yeast cells identified as T. asahii. Microscopy of the isolates showed hyphae, arthroconidia, and blastospores. The isolates were identified as T. asahii by VITEK MS which uses matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) technology. Initially liposomal amphotericin B and micafungin was initiated, but due to lack of clinical and microbiological response, patient was switched to voriconazole. Simultaneously, tacrolimus doses were reduced to one-third in view of interaction with voriconazole. Subsequently, patient improved with resolution of fever and microbiological cure.
Conclusion: This is the first case report of disseminated T. asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole. Azole antifungal are the promising drug of choice for systemic T. asahii infection. Drug interactions should be considered while using these antifungal agents.
Keywords: Trichosporon asahii; combined liver-kidney transplant; immunocompromised hosts; transplant recipient; voriconazole.
© 2019 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures


Similar articles
-
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.Virulence. 2015;6(5):476-86. doi: 10.1080/21505594.2015.1020273. Epub 2015 Mar 9. Virulence. 2015. PMID: 25751127 Free PMC article.
-
MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.Mycoses. 2021 Aug;64(8):918-925. doi: 10.1111/myc.13306. Epub 2021 Jun 1. Mycoses. 2021. PMID: 33998718
-
Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.Mycopathologia. 2021 Mar;186(1):113-117. doi: 10.1007/s11046-020-00525-x. Epub 2021 Jan 3. Mycopathologia. 2021. PMID: 33389484
-
Skin Manifestations of Micafungin Breakthrough Disseminated Trichosporonosis in Acute Megakaryoblastic Leukemia.Med Mycol J. 2024;65(1):17-21. doi: 10.3314/mmj.23-00009. Med Mycol J. 2024. PMID: 38417883 Review.
-
Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.Fungal Genet Biol. 2019 Dec;133:103267. doi: 10.1016/j.fgb.2019.103267. Epub 2019 Sep 9. Fungal Genet Biol. 2019. PMID: 31513917 Review.
Cited by
-
A Case of Fatal Invasive Trichosporonosis in the Setting of Immunosuppression and Post-COVID-19 Pneumonia.Cureus. 2023 Feb 16;15(2):e35079. doi: 10.7759/cureus.35079. eCollection 2023 Feb. Cureus. 2023. PMID: 36949999 Free PMC article.
-
Voriconazole successfully treats intracranial Trichosporon asahii infection in an immunocompetent patient: a rare case report and literature review.Front Med (Lausanne). 2025 Mar 20;12:1560016. doi: 10.3389/fmed.2025.1560016. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40190574 Free PMC article.
-
Subcutaneous gluteal abscess from Trichosporon asahii in an immunocompetent adult.Proc (Bayl Univ Med Cent). 2021 Nov 15;35(2):195-196. doi: 10.1080/08998280.2021.2000844. eCollection 2022. Proc (Bayl Univ Med Cent). 2021. PMID: 35261450 Free PMC article.
-
Trichosporon asahii: emerging challenges in pathogenesis and drug resistance.Future Microbiol. 2025 Mar;20(4):333-343. doi: 10.1080/17460913.2025.2457858. Epub 2025 Jan 27. Future Microbiol. 2025. PMID: 39871602 Review.
-
Trichosporon asahii and Trichosporon inkin Biofilms Produce Antifungal-Tolerant Persister Cells.Front Cell Infect Microbiol. 2021 Apr 22;11:645812. doi: 10.3389/fcimb.2021.645812. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33968802 Free PMC article.
References
-
- Devi KM, Mate PH, Singh LN, Devi KR, Devi KS. Disseminated infection with Trichosporon asahii in an immunocompetent patient: a rare case report. J Med Soc. 2015;29:174‐176.
-
- Kremery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukemia. J Hosp Infect. 1999;41:181‐194. - PubMed
-
- Ebright JR, Fairfax MR, Vazquez JA. Trichosporon asahii, a non‐Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin Infect Dis. 2001;33(5):E28‐E30. - PubMed
-
- Panagopoulou P, Evdoridou J, Bibashi E, et al. Trichosporon asahii an unusual cause of invasive infection in neonates. Pediatr Infect Dis J. 2002;21:169‐170. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical